Slide 1 of 22 Rob Packard, President 510(k) Project Management.

Slides:



Advertisements
Similar presentations
Why is your new product launch behind schedule?
Advertisements

"Determining the Regulatory Pathway to Market" Classification Heather S. Rosecrans Director, 510(k) Staff Office of Device Evaluation Center for Devices.
Strengthening the Medical Device Clinical Trial Enterprise
510k Submission Overview Myraqa, Inc. August 22, 2012.
US Army Corps of Engineers BUILDING STRONG ® Creating a Data Dictionary for Your Local Data USACE SDSFIE Training Prerequisites: Preparing Your Local Data.
eIRB 2 Rational 2004 – Launch of eIRB 2009 – Last major upgrade 2011 – Last quarterly update eIRB Today:  Outdated architecture Increasing memory issues.
Avoiding Pitfalls: Testing Considerations
Combining Product Risk Management & Design Controls
FDA Pre-Submission Meetings for 510(k) Submissions
U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES NATIONAL INSTITUTES OF HEALTH Working with FDA: Biological Products and Clinical Development Critical Path.
PURPOSE OF DFMEA (DESIGN FAILURE MODE EFFECTS ANALYSIS)
Slide 1 of 21 Robert Packard, President Supplier Auditing & Remote Auditing.
Rob Packard, President Slide 1 of 30 Bioburden Failure Analysis An E. coli strain being plated for identification.
Slide 1 of 11 April 2014 Rob Packard, President Regulatory Pathways 101: Your 1 st Product Launch in Canada,
+ Medical Devices Approval Process. + Objectives Define a medical device Be familiar with the classification system for medical devices Understand the.
#PhUSE Standard Scripts Project Proposal for Qualification of Standard Scripts.
GeMS Grant Applicant Information Registering Initiating an application.
EIRB Training IRB Committee Member A Paperless IRB System.
1 THE UNIQUE ROLES OF IRB IN MEDICAL DEVICE CLINICALL TRIAL Chiu Lin, Ph.D. CITI, May, 2009 CITI, May, 2009.
S/W Project Management
Slide 1 of 19 Rob Packard, President
Komen Grants eManagement System GeMS. Why Online Grants  Reduce the amount of administrative paperwork being completed by applicants and grantees. 
What is Sure BDCs? BDC stands for Batch Data Communication and is also known as Batch Input. It is a technique for mass input of data into SAP by simulating.
The Medical Device Pathway as a Legal Onramp for Futuristic Persons THE FUTURE T HE M EDICAL D EVICE P ATHWAY AS A L EGAL.
Creating a Risk-Based CAPA Process
Certification Approaches EAC Meeting Miami, FL August 2008 Gordon Gillerman Conformity Assessment Advisor Homeland Security National Institute of Standards.
Slide 1 of 20 Rob Packard, President FRM-023 A D1 – Management Review Template Management Review Management.
Understanding the Pre-IDE Program: FDA Perspective
Product Development Chapter 6. Definitions needed: Verification: The process of evaluating compliance to regulations, standards, or specifications.
OIVD Workshop Premarket Notification (510(k)) April 22, 2003 Parklawn Building Rockville, MD Presented by Marjorie Shulman Premarket Notification Staff.
New Draft Guidance for Multiplex Tests Elizabeth Mansfield and Michele Schoonmaker Office of In Vitro Diagnostic Device Evaluation and Safety (OIVD) CDRH/FDA.
510(k) Submissions Recent Experience and Perspectives Terry Sullivan Vice President, Regulatory Affairs.
Leukocyte-Reduced Blood Components Lore Fields MT(ASCP)SBB Consumer Safety Officer, DBA, OBRR, CBER September 16, 2009.
This information is confidential and was prepared by Bain & Company solely for the use of our client; it is not to be relied on by any 3rd party without.
Develop Project Charter
Medical Device Consultants, Inc. Investing in a Clinical Program: Advice in a Challenging Economic Time MassMEDIC Medical Device Clinical Trials Update.
Introduction to the ISBT 128 Labelling Standard for Blood Components.
Ivowen Ltd1 Ivowen Limited Preparation and Submission of a Traditional Herbal Medicinal Product Application.
Welcome New IRB Members! Today we will discuss: Your Role in the IRB: What to Know The IRB Review Process Resources Human Research Protections.
Design Documentation Clint Kehres, Brian Krouse, Jenn Shafner.
New York State DOH Health Home Care Management Reporting Tool (HH-CMART) Support Calls – Session #7 April 3,
New York State DOH Health Home Care Management Reporting Tool (HH-CMART) Support Calls – Session #3 March 6,
T Iteration Demo Group name [PP|I1|I2] Iteration
The 510(k) Program Roy Baby, Investigator US Food & Drug Administration 4040 N Central Expressway, Dallas, TX 1.
Welcome New IRB Member! This brief presentation covers: Your Role in the IRB: What to Know The IRB Review Process Resources Human Research Protections.
PROPOSAL Steps to Writing and Revising your Proposal.
AMERICAS | ASIA PACIFIC | EMEA Medical Devices: Concept to Commercialization How to avoid delays in getting your product cleared/approved by FDA Robert.
US FDA Pre-Submissions (Q Subs)
Rev. May 2016 cuResearch User’s Manual. What is cuResearch? Introduction to cuResearch More information is available on the CURO website:
Workshop on conformity assessment procedures and certification of medical devices INT MARKT Kyiv, November 2011 Conformity assessment of medical.
Principal Investigator ESTCP Selection Meeting
eIRB Training IRB Committee Members
T3/Tutorials: Data Submission
Division of Cardiovascular Devices
Pre-Investigational New Drug (pre-IND) Meeting with FDA
Premarket Notification 510(k) process
FDA’s IDE Decisions and Communications
CMIP5 Questionnaire Roadmap – beta
Principal Investigator ESTCP Selection Meeting
Handling ongoing variations concerning same document
CPMGT 300 Competitive Success/snaptutorial.com
CPMGT 300 Education for Service/snaptutorial.com.
CPMGT 300 Teaching Effectively-- snaptutorial.com.
Linda M. Chatwin, Esq. RAC Business Manager, UL LLC
A Practical Introduction to the Clinical Evaluation Report
Principal Investigator ESTCP Selection Meeting
Thoughts on FDA’s Draft Guidances Issued January 2019
Principal Investigator ESTCP Selection Meeting
Click Training Safety Module
Grant Agreement Preparation
Presentation transcript:

Slide 1 of 22 Rob Packard, President 510(k) Project Management

Slide 2 of 22 Rob Packard, President Agenda Overview Device Classification Predicate Selection Table of Contents Team Member Selection Performance Testing Plan FDA Pre-Sub Meetings

Slide 3 of 22 Rob Packard, President 510(k) Overview

Slide 4 of 22 Rob Packard, President Product Classification 1.Identify a device similar to yours 2.Use the registration and listing database 3.Identify the 3-letter product code 4.Click on the code to go to the product classification page 5.Click on the TPLC link

Slide 5 of 22 Rob Packard, President Find Classification Other Ways

Slide 6 of 22 Rob Packard, President Predicate Selection 1.Is the predicate device legally marketed? 2.Do the devices have the same intended use? 3.Do the devices have the same technological characteristics? 4.Do the different technological characteristics raise different questions of safety and effectiveness? 5.Are the methods of evaluating new/different characteristics acceptable? 6.Does the data demonstrate substantial equivalence?

Slide 7 of 22 Rob Packard, President How FDA Evaluates SE?

Slide 8 of 22 Rob Packard, President Section 2 - Table of Contents 20 Sections Create a Template ( ) eCopy Guidance ( ) RTA Checklist ( )

Slide 9 of 22 Rob Packard, President Use ToC as Planning Tool red = the information does not appear to be available yellow = document requires revision and/or reformatting of content blue = ready for the client’s review and approval green = ready for submission Add a column to assign team responsibilities Prioritize task completion

Slide 10 of 22 Rob Packard, President Example of ToC Tool

Slide 11 of 22 Rob Packard, President Team Member Selection Boilerplate – 1, 3, 6 & non-applicable 9 - Declarations of Conformity ( FDA Form 3654 ) Biocompatibility & Sterility – 14 & 15 Software & EMC – 16 & 17 Labeling - 13 Performance Testing – Bench Testing - 18 – Animal Testing - 19 – Clinical Studies – 20 + Sections 7 & 8

Slide 12 of 22 Rob Packard, President Most Critical Sections 4 – Indications for Use (1 st ) (k) Summary (4 th ) 10 – Executive Summary (my last) 11 - Device Description (2 nd ) 12 – Substantial Equivalence (3 rd ) RTA Checklist is a great quality 

Slide 13 of 22 Rob Packard, President Planning Performance Testing Look for a special controls guidance document 1 st. Look for any device-specific standards (e.g., ASTM F483) Review each of the possible 510(k) Summaries carefully Order 510(k) submissions through FOI

Slide 14 of 22 Rob Packard, President Bench Testing ASTM testing methods Simulated use experiments Validation tools (known input data for software/hardware devices) Finite Element Analysis (FEA) Cadaveric studies

Slide 15 of 22 Rob Packard, President Animal Studies The agency allows rationales for reduction of sample number in order to spare the lives of animals. Try to find another submission or 510(k) summary that specifies the number of animals Test more than once per animal or your device and the predicate in each animal (i.e., animal is it’s own control) Small animal vs. large animal and duration…

Slide 16 of 22 Rob Packard, President Human Studies 10-15% of 510(k) submissions require clinical study data Steps: – Study Synopsis – Investigator Package – Protocol Approval – Conduct Study – Summary Report Non-significant risk studies do not require IDE IRB approval is always required Paper data collection vs. electronic data collection

Slide 17 of 22 Rob Packard, President FDA Pre-Sub Meetings Guidance released February 18, 2014 Consultants and RA Experts have used these for years, but weren’t called “pre-sub” meetings Do your homework 1 st In-person vs. Tcon Timing = Prior to Performance Testing Identify Proposed Predicate Device(s)

Slide 18 of 22 Rob Packard, President Pre-Sub Questions Is justification of no carcinogenicity testing acceptable? Does FDA agree with “worst-case” rationale? Is software “moderate level of concern”? Is planned approach for human factors acceptable? Are there concerns of predicate selected? Have an expert present that can “kick you”.

Slide 19 of 22 Rob Packard, President What not to do for Pre-Sub… Do not ask if data is acceptable? Do not bother if you already did your testing? Do not argue, because you don’t have to agree with the agency.

Slide 20 of 22 Rob Packard, President

Slide 21 of 22 Rob Packard, President Q & A

Slide 22 of 22 Rob Packard, President Need a quotation for a 510(k) Submission? Rob Packard rob13485